Kerala Ayurveda's Q4 FY 2025-26 Quarterly Results

Result Summary

• Kerala Ayurveda Ltd reported a 7.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 14.3%.
• Its expenses for the quarter were up by 16.0% QoQ and down 2.7% YoY.
• The net profit increased 60.7% QoQ and decreased 52.0% YoY.
• The earnings per share (EPS) of Kerala Ayurveda Ltd declined at 5.83 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kerala Ayurveda Ltd is a company operating in the wellness and healthcare sector, primarily focusing on Ayurvedic products and services. The firm offers a range of healthcare solutions based on traditional Ayurvedic principles. Its product lineup typically includes herbal supplements, personal care products, and wellness therapies. Ayurveda, being a holistic approach to health and well-being, emphasizes natural remedies and preventive care, which may align with Kerala Ayurveda Ltd's product strategy. However, specific recent developments within the company are not available in the provided data.

Revenue

In Q4FY26, Kerala Ayurveda Ltd reported a total income of ₹36.64 crores. This represents a quarter-over-quarter growth of 7.5% from ₹34.09 crores in Q3FY26 and a year-over-year increase of 14.3% from ₹32.05 crores in Q4FY25. The consistent growth in revenue over both the quarterly and yearly periods reflects a positive trajectory in the company's income generation capabilities. This upward trend in revenue indicates the company's ability to increase its market reach or enhance its sales volume in the recent quarters.

Profitability

The company reported a Profit Before Tax (PBT) of -₹7.98 crores in Q4FY26, showing a significant quarter-over-quarter decline of 82.6% compared to -₹4.37 crores in Q3FY26 and a year-over-year improvement from -₹13.81 crores in Q4FY25. The Tax for Q4FY26 was -₹0.59 crores, showing a dramatic change from 0.23 crores in Q3FY26 and 1.56 crores in Q4FY25. Consequently, the Profit After Tax (PAT) for Q4FY26 also stood at a loss of -₹7.39 crores, compared to -₹4.60 crores in Q3FY26 and -₹15.38 crores in Q4FY25, reflecting a 60.7% quarter-over-quarter decrease and a 52.0% year-over-year improvement. Earnings Per Share (EPS) followed a similar pattern, recorded at -₹5.83 in Q4FY26, compared to -₹3.69 in Q3FY26 and -₹13.68 in Q4FY25, marking a 58.0% quarter-over-quarter decline and a 57.4% year-over-year improvement.

Operating Metrics

In terms of operating metrics, Kerala Ayurveda Ltd saw its Total Expenses rise to ₹44.63 crores in Q4FY26, marking a 16.0% increase from ₹38.46 crores in Q3FY26 and a slight year-over-year decrease of 2.7% from ₹45.86 crores in Q4FY25. The increase in expenses from the previous quarter could be attributed to various factors such as higher production costs, increased marketing expenses, or other operational expenses that are not specified in the provided data. The overall financial performance, as indicated by the various metrics, shows a mixed pattern of growth and challenges, reflecting the complexity of managing profitability in a dynamic market environment.